Monitoring serum beta-2 microglobulin is useful for detecting patients with increased risk of acute rejection during reduction in immunosuppression

By Saraiva Camara N.O.   Nishida S.   Silva M.S.   Pestana J.O.M.   Pereira A.B.   Sesso R.   Pacheco-Silva A.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4158-4159

Elsevier

Access to resources Recommend Favorite

Aluminium and beta-2-microglobulin in kidney transplant recipients

By Malyszko J.   Wolczynski S.   Malyszko J.S.   Mysliwiec M.  

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 580-582

Elsevier

Access to resources Recommend Favorite

Differences in immunoactivation between heart and liver transplanted patients

By Erez E.   Sharoni E.   Erman A.   Ben Ari Z.   Sahar G.   Tur-Kaspa R.   Vidne B.A.   Aravot D.  

Transplantation Proceedings, Vol. 31, Iss. 4, 1999-06 ,pp. : 1883-1884

Elsevier

Access to resources Recommend Favorite

C 2 blood levels in heart-transplanted patients immunosuppressed on a trough level-;based regimen

By Fiocchi R.   Iamele L.   Torre L.   Papageorgiou C.   Gamba A.   Ferrazzi P.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3115-3116

Elsevier

Access to resources Recommend Favorite

Beta-2 microglobulin and serum creatinine for differentiating between immunoactivation and renal failure after liver transplantation

By Erez E.   Ben-Ari Z.   Sharoni E.   Aravot D.   Sahar G.   Tur-Kaspa R.   Vidne B.A.   Erman A.  

Transplantation Proceedings, Vol. 33, Iss. 6, 2001-09 ,pp. : 2920-2923

Elsevier

Access to resources Recommend Favorite